Dietary phenolic compounds as promising therapeutic agents for diabetes and its complications: A comprehensive review
- PMID: 38726403
- PMCID: PMC11077226
- DOI: 10.1002/fsn3.3983
Dietary phenolic compounds as promising therapeutic agents for diabetes and its complications: A comprehensive review
Abstract
In the middle of an ever-changing landscape of diabetes care, precision medicine, and lifestyle therapies are becoming increasingly important. Dietary polyphenols are like hidden allies found in our everyday meals. These biomolecules, found commonly in fruits, vegetables, and various plant-based sources, hold revolutionary potential within their molecular structure in the way we approach diabetes and its intimidating consequences. There are currently numerous types of diabetes medications, but they are not appropriate for all patients due to limitations in dosages, side effects, drug resistance, a lack of efficacy, and ethnicity. Currently, there has been increased interest in practicing herbal remedies to manage diabetes and its related complications. This article aims to summarize the potential of dietary polyphenols as a foundation in the treatment of diabetes and its associated consequences. We found that most polyphenols inhibit enzymes linked to diabetes. This review outlines the potential benefits of selected molecules, including kaempferol, catechins, rosmarinic acid, apigenin, chlorogenic acid, and caffeic acid, in managing diabetes mellitus as these compounds have exhibited promising results in in vitro, in vivo, in silico, and some preclinical trials study. This encompassing exploration reveals the multifaceted impact of polyphenols not only in mitigating diabetes but also in addressing associated conditions like inflammation, obesity, and even cancer. Their mechanisms involve antioxidant functions, immune modulation, and proinflammatory enzyme regulation. Furthermore, these molecules exhibit anti-tumor activities, influence cellular pathways, and activate AMPK pathways, offering a less toxic, cost-effective, and sustainable approach to addressing diabetes and its complications.
Keywords: Anti‐obesity; Enzyme Inhibition; Medicinal Plants; α‐Amylase; α‐Glucosidase.
© 2024 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC.
Conflict of interest statement
There is no conflict of interest between authors.
Figures
![FIGURE 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11077226/bin/FSN3-12-3025-g005.gif)
![FIGURE 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11077226/bin/FSN3-12-3025-g008.gif)
![FIGURE 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11077226/bin/FSN3-12-3025-g003.gif)
![FIGURE 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11077226/bin/FSN3-12-3025-g007.gif)
![FIGURE 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11077226/bin/FSN3-12-3025-g002.gif)
![FIGURE 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11077226/bin/FSN3-12-3025-g004.gif)
![FIGURE 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11077226/bin/FSN3-12-3025-g001.gif)
Similar articles
-
Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms.Molecules. 2023 May 10;28(10):3996. doi: 10.3390/molecules28103996. Molecules. 2023. PMID: 37241737 Free PMC article. Review.
-
Inhibition of α-glucosidase and α-amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays.J Diabetes. 2021 Oct;13(10):779-791. doi: 10.1111/1753-0407.13163. Epub 2021 Feb 23. J Diabetes. 2021. PMID: 33550683
-
Antioxidative and therapeutic potential of selected Australian plants: A review.J Ethnopharmacol. 2021 Mar 25;268:113580. doi: 10.1016/j.jep.2020.113580. Epub 2020 Nov 13. J Ethnopharmacol. 2021. PMID: 33189842 Review.
-
Differential α-amylase/α-glucosidase inhibitory activities of plant-derived phenolic compounds: a virtual screening perspective for the treatment of obesity and diabetes.Food Funct. 2017 May 24;8(5):1942-1954. doi: 10.1039/c7fo00220c. Food Funct. 2017. PMID: 28470323
-
Caffeic and chlorogenic acids inhibit key enzymes linked to type 2 diabetes (in vitro): a comparative study.J Basic Clin Physiol Pharmacol. 2015 Mar;26(2):165-70. doi: 10.1515/jbcpp-2013-0141. J Basic Clin Physiol Pharmacol. 2015. PMID: 24825096
References
-
- Afrin, S. , Giampieri, F. , Gasparrini, M. , Forbes‐Hernández, T. Y. , Cianciosi, D. , Reboredo‐Rodriguez, P. , Zhang, J. , Manna, P. P. , Daglia, M. , Atanasov, A. G. , & Battino, M. (2020). Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved. Biotechnology Advances, 38, 107322. - PubMed
-
- Ahmed, S. , Ali, M. C. , Ruma, R. A. , Mahmud, S. , Paul, G. K. , Saleh, M. A. , Alshahrani, M. M. , Obaidullah, A. J. , Biswas, S. K. , Rahman, M. M. , Rahman, M. M. , & Islam, M. R. (2022). Molecular docking and dynamics simulation of natural compounds from betel leaves (Piper betle L.) for investigating the potential inhibition of alpha‐amylase and alpha‐glucosidase of type 2 diabetes. Molecules, 27(14), 4526. 10.3390/molecules27144526 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources